ALTIMMUNE - PEMVIDUTIDE 2.4 MG ACHIEVES SIGNIFICANT REDUCTION IN HEAVY DRINKING DAYS IN PHASE 2 TRIAL

Reuters · 3d ago

Please log in to view news